Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NUFARM LIMITED Director's Dealing 2007

Apr 9, 2007

65453_rns_2007-04-09_7d6c017a-3764-44c5-84d2-68c5f6d74036.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

10 April 2007

To ASX

Nufarm Limited - Appendix 3Y: Dr WB Goodfellow

On 3 April, we released an Appendix 3Y for Dr WB Goodfellow on behalf of our subsidiary company, Nufarm Finance (NZ) Ltd.

Due to an oversight, we have overlooked first lodging the Appendix 3Y on behalf of Nufarm. We now attach that Appendix 3Y on behalf of Nufarm.

We trust this is satisfactory.

Very best regards

Rodney Heath Company Secretary

Appendix 3Y

Rule 3.19A.2

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity NUFARM LIMITED
ABN - 37 091 323 312 -

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director WILLIAM BRUCE GOODFELLOW
Date of last notice 28/03/07

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the
relevant interest.
Indirect interest in 113,616 shares held by Waikato
Investment Co Ltd purchased by Sulkem Company
Limited, a company controlled by WB Goodfellow.
Date of change 02/04/07

+ See chapter 19 for defined terms.

No. of securities held prior to change Direct:
70,787 Fully paid ord shares
ü
Indirect:
Pacific Custodians Pty Ltd: 37,123 Fully Paid
ä,
Ord Shares
MA Goodfellow: 10,787 Fully Paid Ord Shares
Ű.
St Kentigern Trust: 429,855 Fully Paid Ord
ű
Shares, and 19,727 Nufarm Step-Up Securities
(NSS)
Waikato Investment: 113,616 Fully Paid Ord
ű
Shares
Auckland Medical Research Foundation:
۰
25,462 NSS
Class Fully Paid Ordinary Shares
Number acquired Indirect: 113,616 Fully Paid Ordinary Shares
acquired by Sulkem Company Limited
Number disposed Indirect 113,616 Fully Paid Ordinary Shares
disposed by Waikato Investment Co Ltd.
Value/Consideration
Note: If consideration is non-cash, provide details and
estimated valuation
NZ\$1,538,831.00
No. of securities held after change Direct:
70,787 Fully Paid Ord Shares
۳
Indirect:
Pacific Custodians Pty Ltd: 37,123 Fully Paid
Ű.
Ord Shares
MA Goodfellow: 10,787 Fully Paid Ord Shares
ű
St Kentigern Trust: 429,855 Fully Paid Ord
ø.
Shares and 19,727 NSS
Sulkem Company Limited: 113,616 Fully Paid
ø,
Ord Shares
Auckland Medical Research Foundation:
۰
25,462 NSS
Nature of change Off market transfer
Example: on-market trade, off-market trade, exercise of
options, issue of securities under dividend reinvestment plan,
participation in buy-back

$+$ See chapter 19 for defined terms.

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph $(ii)$ of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities
to.
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details and
an estimated valuation
Interest after change

$\overline{\text{+ See chapter 19}}$ for defined terms.